The Salivary Gland Infection Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Salivary Gland Infection Market?
The market size for salivary gland infection has significantly expanded in the past few years. Progressing from $4.12 billion in 2024, it will reach $4.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Salivary Gland Infection Industry?
The market size for salivary gland infection is predicted to reach $6.09 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.1%.
Download Your Free Sample of the 2025 Salivary Gland Infection Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Salivary Gland Infection Market?
The key drivers in the salivary gland infection market are:
• Rising awareness about oral health
• Growing adoption of minimally invasive procedures
• Increasing prevalence of chronic conditions
• Improvements in healthcare infrastructure and patient access to specialized care
Global Market Segmentation: Identifying Major Salivary Gland Infection Industry Segments
The salivary gland infection market covered in this report is segmented –
1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User
Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test
Pre-order the 2025 Salivary Gland Infection Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Salivary Gland Infection Market?
The key trends in the salivary gland infection market are:
• Adoption of minimally invasive procedures is a notable emerging trend.
• Technological advancements like advanced sialendoscopy techniques and imaging technologies are shaping the market.
• Development of biocompatible stents and adoption of robotic-assisted surgeries are also influencing the future of the market.
• Integration of targeted antimicrobial therapies and AI-driven diagnostic tools are other significant trends.
Who Are the Top Competitors & Leading Players in the Salivary Gland Infection Market?
Major players in the salivary gland infection market are:
• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Merck & Co. Inc.
• AbbVie Inc.
• AstraZeneca plc
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Gilead Sciences, Inc.
• Amgen Inc.
• FUJIFILM Holdings Corporation
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Astellas Pharma Inc.
• Sandoz International GmbH
• Vertex Pharmaceuticals Incorporated
• Incyte Corporation.
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Vanda Pharmaceuticals Inc.
• Mylan N.V.
• Zydus Cadila Healthcare Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the salivary gland infection market in 2024
